Seguir
Paul Edward Sax
Paul Edward Sax
Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School
Dirección de correo verificada de bwh.harvard.edu
Título
Citado por
Citado por
Año
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
ES Rosenberg, JM Billingsley, AM Caliendo, SL Boswell, PE Sax, ...
Science 278 (5342), 1447-1450, 1997
23871997
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
International HIV Controllers Study
Science 330 (6010), 1551-1557, 2010
11492010
Transmission of SARS-CoV-2: a review of viral, host, and environmental factors
EA Meyerowitz, A Richterman, RT Gandhi, PE Sax
Annals of internal medicine 174 (1), 69-79, 2021
10922021
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel
HF Günthard, MS Saag, CA Benson, C Del Rio, JJ Eron, JE Gallant, ...
Jama 316 (2), 191-210, 2016
9072016
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy
C Hadigan, JB Meigs, C Corcoran, P Rietschel, S Piecuch, N Basgoz, ...
Clinical Infectious Diseases 32 (1), 130-139, 2001
8902001
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two …
PE Sax, D Wohl, MT Yin, F Post, E DeJesus, M Saag, A Pozniak, ...
The Lancet 385 (9987), 2606-2615, 2015
772*2015
The survival benefits of AIDS treatment in the United States
RP Walensky, AD Paltiel, E Losina, LM Mercincavage, BR Schackman, ...
The Journal of infectious diseases 194 (1), 11-19, 2006
7542006
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel
MS Saag, CA Benson, RT Gandhi, JF Hoy, RJ Landovitz, MJ Mugavero, ...
Jama 320 (4), 379-396, 2018
7352018
Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials
PE Sax, KM Erlandson, JE Lake, GA Mccomsey, C Orkin, S Esser, ...
Clinical Infectious Diseases 71 (6), 1379-1389, 2020
7132020
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz …
GA McComsey, D Kitch, ES Daar, C Tierney, NC Jahed, P Tebas, L Myers, ...
Journal of Infectious Diseases 203 (12), 1791-1801, 2011
6162011
The lifetime cost of current human immunodeficiency virus care in the United States
BR Schackman, KA Gebo, RP Walensky, E Losina, T Muccio, PE Sax, ...
Medical care 44 (11), 990-997, 2006
6042006
Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1
S Naggie, C Cooper, M Saag, K Workowski, P Ruane, WJ Towner, ...
New England Journal of Medicine 373 (8), 705-713, 2015
5782015
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a …
PE Sax, E DeJesus, A Mills, A Zolopa, C Cohen, D Wohl, JE Gallant, ...
The Lancet 379 (9835), 2439-2448, 2012
5452012
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
M Altfeld, ES Rosenberg, R Shankarappa, JS Mukherjee, FM Hecht, ...
The Journal of experimental medicine 193 (2), 169-180, 2001
5202001
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA Panel
MS Saag, RT Gandhi, JF Hoy, RJ Landovitz, MA Thompson, PE Sax, ...
Jama 324 (16), 1651-1669, 2020
5142020
Metformin in the treatment of HIV lipodystrophy syndrome: a randomized controlled trial
C Hadigan, C Corcoran, N Basgoz, B Davis, P Sax, S Grinspoon
Jama 284 (4), 472-477, 2000
4782000
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials
JB Nachega, JJ Parienti, OA Uthman, R Gross, DW Dowdy, PE Sax, ...
Clinical infectious diseases 58 (9), 1297-1307, 2014
4762014
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy
JS Currier, JD Lundgren, A Carr, D Klein, CA Sabin, PE Sax, JT Schouten, ...
Circulation 118 (2), e29-e35, 2008
4602008
Dolutegravir in antiretroviral-experienced patients with raltegravir-and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study
A Castagna, F Maggiolo, G Penco, D Wright, A Mills, R Grossberg, ...
The Journal of infectious diseases 210 (3), 354-362, 2014
4472014
Abacavir–lamivudine versus tenofovir–emtricitabine for initial HIV-1 therapy
PE Sax, C Tierney, AC Collier, MA Fischl, K Mollan, L Peeples, C Godfrey, ...
New England Journal of Medicine 361 (23), 2230-2240, 2009
4402009
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20